MGO One Seven’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
MGO One Seven's ALNY Position: Q3 2026 in Review
MGO One Seven sold out of Alnylam Pharmaceuticals (ALNY) in Q3 2026, closing a stake of 880 shares — an estimated $265K sold.
MGO One Seven first reported a position in ALNY in Q4 2017 and held it in 7 quarters. The position peaked at $331K in Q4 2025. 722 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.
- MGO One Seven reported no remaining Alnylam Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- MGO One Seven sold 880 Alnylam Pharmaceuticals shares in Q3 2026, an estimated $265K.
- MGO One Seven first reported a position in Alnylam Pharmaceuticals in Q4 2017 and held it in 7 quarters.
- MGO One Seven's Alnylam Pharmaceuticals position peaked at $331K in Q4 2025.
- 722 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.
Based on MGO One Seven's 13F filing for Q3 2026, filed 28 Oct 2026.